MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Exploring the Therapeutic Target for Lewy Body Disease using gba1 Knock-out Medaka

    E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, H. Yamakado, R. Takahashi (kyoto, Japan)

    Objective: This study was performed to explore the therapeutic target for Lewy body disease. Background: Lewy body disease (LBD), including Parkinson's disease and diffuse Lewy…
  • 2024 International Congress

    Sphingomyelinase Activity in Patients with Sporadic Parkinson’s Disease

    A. Rekik, A. Mili, S. Naija, E. Jarrar, K. Jemai, A. Hassine, S. Ben Amor, J. Ben Abdallah (Sousse, Tunisia)

    Objective: To measure the sphingomyelinase (ASMase) activity in sporadic PD patients and matched healthy controls and identify any clinical or biological correlation with disease’s severity.To…
  • 2024 International Congress

    Machine Learning Model Comparison for Freezing of Gait Prediction in Advanced Parkinson’s Disease Patients

    J. Watts, A. Khojandi, R. Ramdhani (Knoxville, USA)

    Objective: This study compares the performance of machine learning classification models in predicting freezing of gait (FoG) from instrumented stand-and-walk trials in advanced Parkinson’s disease…
  • 2024 International Congress

    Use of Machine Learning for Identification of Parkinson’s Disease and Mild Cognitive Impairment through Neuroimaging and Biofluid Biomarkers: A Study from the PPMI Cohort

    A-G. Dennis, A. Strafella (Toronto, Canada)

    Objective: Since current diagnostic tests for Parkinson’s Disease (PD) and mild cognitive impairment (MCI) focus on individual biomarkers, misdiagnoses can be frequent. This research aims…
  • 2024 International Congress

    the Degeneration of Locus Coeruleus and its Enhanced Causal Relationship to Neural Circuit in Parkinson’s Tremor

    JY. Sun (Beijing, China)

    Objective: We aim to decode the neuroimaging features of LC in Parkinson's tremor. Background: Tremor is the primary symptom of Parkinson's disease (PD) and exhibits…
  • 2024 International Congress

    Effects of striatal dopamine depletion and altered brain metabolism on Parkinson’s disease

    HS. Yoo, PH. Lee, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To investigate the relationship between striatal dopamine depletion, altered brain metabolism, motor deficits, and cognitive dysfunction in Parkinson’s disease (PD) Background: PD shows degeneration…
  • 2024 International Congress

    Assessment of Visual Field in Patients with Moderate-to-Severe Parkinson’s Disease

    S. Mehta, M. Syed, S. Naghizadehkashani, K. Shivok, L. Krisa, C. Matias, C. Wu, T. Liang, R. Sergott, M. Alizadeh (Philadelphia, USA)

    Objective: Utilization of visual field testing and diffusion tensor imaging (DTI) to assess visual field deficits in patients with moderate-to-severe Parkinson’s Disease (PD) and identify…
  • 2024 International Congress

    Predictive elements for unilateral prelemniscal radiations radiofrequency lesions: A novel surgical approach for alleviating motor symptoms in Parkinson’s disease

    A. Armas-Salazar, J. Navarro-Olvera, F. Velasco-Campos, F. Jimenez-Ponce, G. Aguado-Carrillo, J. Beltran, J. Carrillo-Ruiz (Mexico City, Mexico)

    Objective: A cohort of individuals diagnosed with Parkinson's disease (PD) underwent treatment with unilateral prelemniscal radiation radiofrequency lesions (U-Raprl). This research seeks to assess prognostic…
  • 2024 International Congress

    Cluster Analysis of Stimulation-Induced Dysarthria Subtypes in People with Parkinson’s Disease and Subthalamic Deep Brain Stimulation

    H. Jergas, JN. Petry-Schmelzer, JH. Hannemann, T. Thies, I. Rubi-Fessen, J. Quinting, V. Visser-Vandewalle, T. Tsuboi, MT. Barbe (Cologne, Germany)

    Objective: To establish different clusters with distinctive speech characteristics in people with Parkinson’s disease (PwPD) who experience stimulation-induced dysarthria (SID). Background: To date, the effect…
  • 2024 International Congress

    Longevity of Motor Benefit Achieved with Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) in a Single Center Cohort at the Decade Mark Post-Implantation.

    D. Caputo, R. Dipaola, S. Danish, E. Hargreaves (Neptune, USA)

    Objective: To track the degree and longevity of motor benefit achieved with STN DBS at our center. Background: Caputo et al., (2017)[1]  presented data from…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley